Royalty Pharma PLC reports results for the quarter ended in December - Earnings Summary

Royalty Pharma

15/02/2023 14:32

* Royalty Pharma PLC  RPRX.OQ  reported quarterly adjusted
earnings of $1.56​​ per share for the quarter ended in December.
The mean expectation of eight analysts for the quarter was
for earnings of $1.47 per share.
    * Revenue fell 1.7% to $566.00 million from a year ago;
analysts
expected $951.29 million. 
    * Royalty Pharma PLC's reported EPS for the quarter was a
loss
of 75 cents​.
    * The mean earnings estimate of analysts had risen by
about 12.5%
in the last three months.​ 
    * In the last 30 days one analyst negatively revised an
earnings
estimate 
    * Royalty Pharma PLC shares had fallen by 4.4% this quarter.
    * The company reported a quarterly loss of $456 million.
    * Wall Street's median 12-month price target for Royalty
Pharma
PLC is $53.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data February
15 at 02:31 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      1.47           1.56           Beat
 Sep. 30 2022      0.72           0.72           Met
 Jun. 30 2022      0.78           0.79           Beat
 Mar. 31 2022      0.73           0.60           Missed